Identification of cluster of differentiation molecule-associated microRNAs as potential therapeutic targets for

Hanyu Zhang1,2, Mingxing Li1,2, Parham Jabbarzadeh Kaboli1,2

  • 1Laboratory of Molecular Pharmacology, Department of Pharmacology, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan, PR China.

Abstract

Insights

This study identifies specific microRNAs (miR-200a, miR-559, miR-1236) associated with cluster of differentiation molecules in gastrointestinal cancers. These findings offer potential new biomarkers for cancer immunotherapy and patient prognosis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Cluster of differentiation (CD) molecules are immune cell markers and potential cancer immunotherapy targets.
  • MicroRNAs (miRNAs) are crucial in cancer, but their link with CD molecules in gastrointestinal (GI) cancers is underexplored.
  • Understanding miRNA-CD molecule interactions may reveal new prognostic and therapeutic strategies for GI cancers.

Purpose of the Study:

  • To investigate the relationship between microRNAs and cluster of differentiation molecules in various gastrointestinal cancers.
  • To identify specific microRNAs associated with CD molecules as potential prognostic biomarkers.
  • To explore novel therapeutic targets for gastrointestinal cancer immunotherapy.

Main Methods:

  • Utilized bioinformatics tools (Targetscan, Starbase, DIANA microT, miRDB) to predict miRNA-CD molecule correlations.
  • Analyzed The Cancer Genome Atlas (TCGA) data for miRNA and CD molecule expression in gastric, colon, rectal, pancreatic, and esophageal cancers.
  • Employed Kaplan-Meier analysis to assess the association between CD molecule-associated miRNA expression and overall survival.

Main Results:

  • Identified negative associations between miR-200a/CD86, miR-559/CD81, and miR-1236/CD160 across multiple GI cancer types.
  • Validated these miRNA-CD molecule associations in vitro using miRNA mimics in relevant cancer cell lines (gastric, colon, pancreatic, esophageal).

Conclusions:

  • miR-200a, miR-559, and miR-1236 are confirmed as cluster of differentiation-associated microRNAs in gastrointestinal cancers.
  • These miRNAs represent novel targets for cancer immunotherapy and potential prognostic biomarkers in GI cancer patients.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.4K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.9K